FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Amy Goodwin

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Disorders

Substance-Related Disorders

Co-author Network

Publications

TOP 3
Amy K Goodwin; Melanie Mueller; George A Ricaurte; Courtney D Shell; Nancy A Ator
Behavioral Effects and Pharmacokinetics of ({+/-})-3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) after Intragastric Administration to Baboons.
Amy K Goodwin; Barbara J Kaminski; Elise M Weerts
Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.
Melanie Mueller; Nancy A Ator; Amy K Goodwin; Una D McCann; George A Ricaurte
Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Amy Goodwin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Amy K Goodwin; Melanie Mueller; George A Ricaurte; Courtney D Shell; Nancy A Ator
Behavioral Effects and Pharmacokinetics of ({+/-})-3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) after Intragastric Administration to Baboons.
The Journal of pharmacology and experimental therapeutics 2013;345(3):342-53.
2013: Amy K Goodwin; Barbara J Kaminski; Elise M Weerts
Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.
Psychopharmacology 2013;225(3):637-46.
2011: Melanie Mueller; Nancy A Ator; Amy K Goodwin; Una D McCann; George A Ricaurte
Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.
The Journal of pharmacology and experimental therapeutics 2011;338(1):310-7.
2011: Amy K Goodwin; Barbara J Kaminski; Roland R Griffiths; Nancy A Ator; Elise M Weerts
Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboons.
Drug and alcohol dependence 2011;114(2-3):217-24.
2009: A Kim; Andrea Gillespie; Eva Dombi; Amy K Goodwin; W Goodspeed; Elizabeth Fox; FRANK BALIS; BRIGITTE WIDEMANN
Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas.
Neurology 2009;73(16):1273-9.
2009: Amy K Goodwin; P Rand Brown; E E W Jansen; Cornelis Jakobs; K Michael Gibson; Elise M Weerts
Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.
Psychopharmacology 2009;204(3):465-76.
2008: Barbara J Kaminski; Amy K Goodwin; Gary S Wand; Elise M Weerts
Dissociation of alcohol-seeking and consumption under a chained schedule of oral alcohol reinforcement in baboons.
Alcoholism, clinical and experimental research 2008;32(6):1014-22.
2007: Elise M Weerts; William E Fantegrossi; Amy K Goodwin
The value of nonhuman primates in drug abuse research.
Experimental and clinical psychopharmacology 2007;15(4):309-27.
2006: Elise M Weerts; Amy K Goodwin; Barbara J Kaminski; Robert D Hienz
Environmental cues, alcohol seeking, and consumption in baboons: effects of response requirement and duration of alcohol abstinence.
Alcoholism, clinical and experimental research 2006;30(12):2026-36.
2006: Amy K Goodwin; Roland R Griffiths; P Rand Brown; Wolfgang Froestl; Cornelis Jakobs; K Michael Gibson; Elise M Weerts
Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons.
Psychopharmacology 2006;189(1):71-82.
2006: Eduard A Struys; Nanda M Verhoeven; Erwin E W Jansen; Herman J Ten Brink; Maneesh Gupta; Terry Burlingame; Lawrence S Quang; Timothy J Maher; Piero Rinaldo; O Carter Snead; Amy K Goodwin; Elise M Weerts; P Rand Brown; Tonya C Murphy; Matthew J Picklo; Cornelius Jakobs; K Michael Gibson
Metabolism of gamma-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenase.
Metabolism: clinical and experimental 2006;55(3):353-8.
2005: Amy K Goodwin; Wolfgang Froestl; Elise M Weerts
Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons.
Psychopharmacology 2005;180(2):342-51.
2005: Elise M Weerts; Amy K Goodwin; Roland R Griffiths; P Rand Brown; Wolfgang Froestl; Cornelis Jakobs; K Michael Gibson
Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons.
Psychopharmacology 2005;179(3):678-87.
2003: Amy K Goodwin; Dori M Pynnonen; Lisa E Baker
Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination.
Pharmacology, biochemistry, and behavior 2003;74(4):987-95.
2002: Amy K Goodwin; Lisa E Baker
An analysis of the utility of differential outcome procedures in drug discrimination research.
Behavioural pharmacology 2002;13(4):271-8.
2001: A J Christian; Amy K Goodwin; Lisa E Baker
Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A.
Pharmacology, biochemistry, and behavior 2001;68(3):371-7.
2000: Amy K Goodwin; Lisa E Baker
A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats.
Experimental and clinical psychopharmacology 2000;8(3):415-23.
1998: Lisa E Baker; KA Svensson; K J Garner; Amy K Goodwin
The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.
European journal of pharmacology 1998;358(2):101-9.